for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Biotech Roivant to go public via $7.3 bln SPAC deal

May 3 (Reuters) - Roivant Sciences said on Monday it would go public through a merger with blank-check firm Montes Archimedes Acquisition Corp in a deal that values the biotech company at $7.3 billion. (Reporting by Niket Nishant in Bengaluru; Editing by Ramakrishnan M.)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up